TRU and Genome B.C. have formed a partnership, details of which the two will announce on Thursday, Dec. 3.
The partnership involves financial support from Genome B.C. for a unique research chair position at the university.
Established in year 2000, Genome B.C. has a number of partnerships with post-secondary institutions in the province.
The agency serves as “a catalyst for the life sciences cluster on Canada’s West Coast,” and manages a portfolio of more than $710 million in 254 research projects as well as science and technology platforms. Working with governments, academia and industry, the organization aims at generating social and economic benefits.
Last week, Genome B.C. announced a new research project to use “reverse vaccinology” to develop vaccines for Johne’s disease and bovine tuberculosis in cattle. These diseases result in annual losses of more than $86 million and $10 million, respectively, in Canada and B.C., and billions annually lost worldwide.